Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy (MazF)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01787994
First received: January 31, 2013
Last updated: May 3, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)